P Dang

902 total citations
8 papers, 605 citations indexed

About

P Dang is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, P Dang has authored 8 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Rheumatology and 3 papers in Hematology. Recurrent topics in P Dang's work include Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). P Dang is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). P Dang collaborates with scholars based in Australia, United States and Vietnam. P Dang's co-authors include William K. Evans, Frances A. Shepherd, Ronald Feld, David Osoba, George Deboer, Timothy P. Hughes, Andrew Grigg, Cassandra Slader, John F. Seymour and Anthony K. Mills and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Leukemia.

In The Last Decade

P Dang

7 papers receiving 587 citations

Peers

P Dang

ONCOL

HEMAT

GENET

EPIDE

MB

Sara Burcheri Italy

Srinivas K. Tantravahi United States

Marianne Rosamilia United States

Elena Trabacchi Italy

Parth Desai United States

Dariusz Woszczyk Poland

Atsushi Shinagawa Japan

Tariq Muzzafar United States

Naresh Bumma United States

Guillermo Martín–Núñez Spain

Sara Burcheri Italy

P Dang

218 ×0.7

ONCOL

219 ×0.8

HEMAT

343 ×1.5

GENET

39 ×0.2

EPIDE

160 ×0.9

MB

Citations per year, relative to P Dang P Dang (= 1×) peers Sara Burcheri

Countries citing papers authored by P Dang

Since Specialization

Citations

This map shows the geographic impact of P Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Dang more than expected).

Fields of papers citing papers by P Dang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Dang. The network helps show where P Dang may publish in the future.

Co-authorship network of co-authors of P Dang

This figure shows the co-authorship network connecting the top 25 collaborators of P Dang. A scholar is included among the top collaborators of P Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Dang. P Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Huynh, Hien Q., et al.. (2025). Regional citrate anticoagulation for continuous renal replacement therapy: a prospective study in a resource-limited intensive care unit from Vietnam. Journal of Nephrology. 38(3). 959–968.

2.

Dang, P, et al.. (2024). Equity in Digital Health: Assessing Access and Utilization of Remote Patient Monitoring, Medical Apps, and Wearables in Underserved Communities. INQUIRY The Journal of Health Care Organization Provision and Financing. 61. 2876864865–2876864865. 2 indexed citations

3.

Eadie, Laura N, P Dang, David T Yeung, et al.. (2016). The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment. Leukemia. 31(1). 75–82. 55 indexed citations

4.

Dang, Nguyen Dinh, et al.. (2013). Lymph Node Management in 255 Patients With Paratesticular Rhabdomyosarcoma: A Population-Based Analysis. International Journal of Radiation Oncology*Biology*Physics. 86(4). 800–800. 2 indexed citations

5.

White, Deborah L., Jerald P. Radich, Simona Soverini, et al.. (2011). Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib. Haematologica. 97(6). 907–914. 44 indexed citations

6.

Ross, David M., Susan Branford, John F. Seymour, et al.. (2010). Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia. 24(10). 1719–1724. 194 indexed citations

7.

Shepherd, Frances A., William K. Evans, Jonathan C. Yau, et al.. (1988). Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract.. Journal of Clinical Oncology. 6(2). 253–260. 62 indexed citations

8.

Evans, William K., Frances A. Shepherd, Ronald Feld, et al.. (1985). VP-16 and cisplatin as first-line therapy for small-cell lung cancer.. Journal of Clinical Oncology. 3(11). 1471–1477. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact